Waldelactone

Waldelactone: Assessment of Available Evidence

Important notice on sourcing: This article was prepared following a systematic search of peer-reviewed biomedical literature (PubMed/PMC), government health databases (NIH Office of Dietary Supplements, NIH/NCCIH, WHO, EMA, EFSA), official pharmacopeias (USP, European Pharmacopoeia, WHO monographs, German Commission E, ESCOP), and rigorously-referenced evidence databases (Examine.com). The strict sourcing rules governing this article require that every factual claim be grounded in one of those authoritative source tiers, and prohibit the invention or extrapolation of facts, mechanisms, dosages, study results, or citations.

After exhaustive search across all of those source tiers, no credible, peer-reviewed, or officially recognised scientific or regulatory record for a dietary supplement or natural ingredient called "Waldelactone" could be located. The term does not appear in PubMed, PMC, Cochrane, WHO monographs, ESCOP, the German Commission E, the USP, the European Pharmacopoeia, the NIH Dietary Supplement Label Database, the NIH Dietary Supplement Ingredient Database, EFSA's compendium of botanical ingredients, or Examine.com. No clinical trials, in-vivo studies, in-vitro studies, or traditional-use monographs bearing this name were identified in any of those databases.

Possible Sources of Confusion

Several real phytochemicals carry superficially similar names, and it is possible that "Waldelactone" is a misspelling, a colloquial name, a proprietary trade designation, or a conflation of one of the following documented compounds:

• Wedelolactone — a coumestan (polyphenolic lactone) isolated from Eclipta alba (L.) Hassk. (family Asteraceae), which has a substantial peer-reviewed literature covering anti-inflammatory, hepatoprotective, and anticancer properties in preclinical models. It is a distinct compound with a distinct chemical structure and is not interchangeable with "Waldelactone."
• Isocoumarin / dihydroisocoumarin lactones — a broad class of lactonic phytochemicals found widely across fungi, lichens, and higher plants (including families Apiaceae, Asteraceae, Leguminosae, and others), none of which are individually named "Waldelactone" in the peer-reviewed literature.
• Phthalide lactones from Ligusticum species — including Z-ligustilide, butylidenephthalide, and ferulic acid derivatives, which are well-characterised constituents of traditionally used Ligusticum species, but none carry the name "Waldelactone."
• Sesquiterpene lactones — a large class of bioactive plant-derived lactones (e.g., from Asteraceae spp.) documented in the phytochemistry literature; again, none are named "Waldelactone" in any authoritative source.

Why a Full Encyclopedic Article Cannot Be Written

The instructions for this article require that every factual claim — including chemical identity, botanical source, traditional use, mechanism of action, clinical evidence, dosage, and safety data — be grounded in a verifiable authoritative source, and explicitly prohibit inventing or guessing any such detail. Because no authoritative source establishes the existence, chemical identity, botanical origin, pharmacological properties, dosages, or safety profile of a compound or ingredient called "Waldelactone," writing a comprehensive reference article on this subject would require fabricating all of those facts. Doing so would be a direct violation of the sourcing and accuracy rules governing this article and would produce demonstrably false health and scientific information.

Recommendation

If you encountered the name "Waldelactone" in a specific context — such as a product label, a research paper, a patent, or another source — providing that source would allow a targeted search to determine whether the name refers to a real compound under an alternative or regional designation. If the intended subject is Wedelolactone (from Eclipta alba), that compound has a genuine peer-reviewed scientific record and a comprehensive, fully sourced encyclopedic article on it can be written from authoritative literature.

References

• PubMed — National Library of Medicine (searched: "Waldelactone"; no results returned)
• PubMed Central (PMC) — full-text biomedical archive (searched: "Waldelactone"; no results returned)
• NIH Office of Dietary Supplements — Ingredient and Label Databases (no entry for "Waldelactone")
• NIH National Center for Complementary and Integrative Health (no entry for "Waldelactone")
• European Medicines Agency — Herbal Medicines (no entry for "Waldelactone")
• EFSA — Compendium of Botanical Ingredients (no entry for "Waldelactone")
• Examine.com — Evidence-based supplement reference (no entry for "Waldelactone")
• Wedelolactone PMC article (example of a real, similarly-named phytochemical with peer-reviewed documentation): "Wedelolactone, an anti-inflammatory botanical, interrupts c-Myc oncogenic signaling" — PMC5096967